Opinion
Accepted on 03 Jun 2025
First reports of illegal fentanyl sales in Peru: the beginning of a crisis?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1616610
Type at least 3 characters
560 articles
Case Report
Published on 03 Jun 2025
Case Report: Potential of pharmacological treatment for auditory abnormal sensations with aripiprazole: a report of two cases
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1614500
- 177 views
Systematic Review
Accepted on 31 May 2025
Adverse events of pharmacological interventions for insomnia disorder in adults: a systematic review and network meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1461166
- 109 views
Brief Research Report
Published on 30 May 2025
Higher clozapine concentration-to-dose ratios at week 1 after initiation are associated with increased risk of clozapine-associated fever in Japanese patients with schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1591568
- 367 views
Original Research
Accepted on 29 May 2025
Attitudes Toward Lithium Prescription Among Psychiatrists in Saudi Arabia: A Cross-sectional Study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1609038
- 169 views
Original Research
Accepted on 20 May 2025
Efficacy and Tolerability of Vortioxetine Monotherapy in SSRI-Resistant OCD: A Retrospective Multicenter Study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1617345
- 364 views
Perspective
Accepted on 15 May 2025
Optimizing the Diagnosis and Treatment of Depression in Primary Care: The Emerging Role of Vortioxetine Treatment
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1568777
- 101 views
Original Research
Accepted on 14 May 2025
Investigating depression in Multiple Sclerosis: an Italian Delphi Consensus on clinical manifestations, diagnosis and treatment
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1557335
- 164 views
Original Research
Published on 13 May 2025
Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1538996
- 686 views
Case Report
Published on 01 May 2025
The role of dulaglutide in the treatment of alcohol use disorder: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1420316
- 1,431 views
Review
Published on 28 Apr 2025
Benzos (as) needed: research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1569416
- 1,342 views
Editorial
Published on 23 Apr 2025
Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1600812
- 1,108 views
Systematic Review
Published on 15 Apr 2025
Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1476449
- 1,094 views
Case Report
Published on 09 Apr 2025
Acute myasthenia caused by lithium: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1467267
- 921 views
- 1 citation
Opinion
Published on 08 Apr 2025
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1565852
- 2,011 views
Original Research
Published on 27 Mar 2025
Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1542000
- 1,028 views